Healthpeak Properties, Inc. $DOC Shares Sold by Hsbc Holdings PLC

Key Points

• Hsbc Holdings PLC reduced its Healthpeak Properties stake by 12.8% in the second quarter, selling 431,633 shares and retaining 2.95 million shares worth approximately $63.3 million. Institutional investors collectively own 93.57% of DOC stock.
• Analysts remain generally cautious, with a consensus “Hold” rating and an average price target of $21.66; several firms raised their targets to between $21.50 and $22.00.
• Healthpeak exceeded quarterly earnings and revenue estimates, reporting $0.08 EPS and $771.6 million in revenue, while announcing a monthly dividend of $0.1017 per share, equivalent to a 5.7% annualized yield.

Hsbc Holdings PLC reduced its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 12.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,952,394 shares of the real estate investment trust's stock after selling 431,633 shares during the quarter. Hsbc Holdings PLC owned about 0.43% of Healthpeak Properties worth $63,263,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Norges Bank bought a new position in Healthpeak Properties in the 4th quarter valued at about $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Healthpeak Properties by 694.6% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust's stock worth $153,520,000 after acquiring an additional 7,007,777 shares during the period. Bank of New York Mellon Corp boosted its holdings in shares of Healthpeak Properties by 60.3% in the first quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust's stock valued at $253,949,000 after acquiring an additional 5,815,189 shares in the last quarter. Fuller & Thaler Asset Management Inc. boosted its holdings in shares of Healthpeak Properties by 19.2% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust's stock valued at $476,744,000 after acquiring an additional 4,776,056 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its holdings in shares of Healthpeak Properties by 214.0% in the second quarter. Massachusetts Financial Services Co. MA now owns 4,230,551 shares of the real estate investment trust's stock valued at $98,050,000 after acquiring an additional 2,883,382 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.

Analyst Ratings Changes

A number of research firms have weighed in on DOC. Citigroup upped their target price on Healthpeak Properties from $20.00 to $22.00 and gave the stock a "neutral" rating in a research report on Tuesday, August 11th. Raymond James Financial began coverage on Healthpeak Properties in a research report on Wednesday, June 17th. They set a "market perform" rating on the stock. UBS Group boosted their price objective on Healthpeak Properties from $19.00 to $21.50 and gave the stock a "neutral" rating in a research note on Wednesday, July 8th. Weiss Ratings raised Healthpeak Properties from a "hold (c)" rating to a "hold (c+)" rating in a research note on Wednesday, August 19th. Finally, Wells Fargo & Company lifted their target price on Healthpeak Properties from $20.00 to $22.00 and gave the stock an "equal weight" rating in a report on Wednesday, July 15th. Four analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $21.66.

Healthpeak Properties Stock Down 0.6%

DOC stock opened at $21.54 on Thursday. The firm has a market cap of $14.85 billion, a PE ratio of 61.54, a P/E/G ratio of 2.36 and a beta of 1.01. Healthpeak Properties, Inc. has a 12 month low of $15.70 and a 12 month high of $22.95. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.02 and a quick ratio of 3.02. The firm has a 50 day simple moving average of $21.48 and a 200 day simple moving average of $19.14.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.05. The firm had revenue of $771.58 million for the quarter, compared to analyst estimates of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm's quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Equities research analysts forecast that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 5.7%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties's dividend payout ratio is currently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source